Synlogic (STU:MIN) Institutional Ownership: 0.12% (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:MIN Synlogic Inc STU:MIN
28 GF Score
Price €3.63
GF Value €0.15
! 1 Warning Sign
View Full Analysis

What is Synlogic Institutional Ownership?

Synlogic STU:MIN 28 Institutional Ownership is 0.12% as of Jul. 17, 2026. GuruFocus rates STU:MIN with a GF Score™ of 28/100 and a GF Value™ of €0.15. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Synlogic's institutional ownership is 0.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Synlogic's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Synlogic's Float Percentage Of Total Shares Outstanding is 44.80%.

Synlogic Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Synlogic's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synlogic Institutional Ownership Chart

Synlogic Historical Data

The historical data trend for Synlogic can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 3.43 3.43 3.40 3.44 1.63 1.63 0.13 0.12 0.12 0.12
STU:MIN
28GF Score
Synlogic Inc STU:MIN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synlogic Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.12% mean?
Synlogic (STU:MIN) has a Institutional Ownership of 0.12% as of Jul. 17, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Synlogic and its competitors.
Is Synlogic's Institutional Ownership too high?
Synlogic's current Institutional Ownership is 0.12%. Overall, Synlogic has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Synlogic's Institutional Ownership compare to ASBP and PMCB?
Synlogic's Institutional Ownership of 0.12% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Synlogic and its competitors. Synlogic's current Institutional Ownership is 0.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synlogic stock overvalued right now?
Synlogic (STU:MIN) has a current Institutional Ownership of 0.12%. The stock's GF Value™ is €0.15, compared to a current price of €3.63 — trading 2320% above its estimated fair value. The current Institutional Ownership is 0.12%. Synlogic's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Synlogic (STU:MIN), the current Institutional Ownership is 0.12% as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synlogic (STU:MIN) Overvalued in 2026?

Based on GuruFocus' analysis, Synlogic stock appears to be overvalued. The current stock price of €3.63 is trading 2320% above its estimated GF Value™ of €0.15.

Key valuation signals for STU:MIN:

  • Institutional Ownership: 0.12%
  • GF Value™: €0.15 vs. price of €3.63 (2320% above fair value)
  • GF Score™: 28/100 with 1 warning sign

No single metric tells the full story. See the STU:MIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synlogic Business Description

Other Exchanges SYBX:USA0A8U:UK
Address PO Box 30, Winchester, MA, USA, 01890
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. The pipeline drug candidates includes: labafenogene marselecobac (SYNB1934); SYNB1353 Classical Homocystinuria (HCU); SYNB8802 Enteric Hyperoxaluria; and SYNB2081 Gout. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one operating segment: Discovery and development of Synthetic Biotics.
28GF Score

Get the complete analysis for STU:MIN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.63
Price
€0.15
GF Value